Hormonal events during female puberty in relation to breast cancer risk

European Journal of Cancer Prevention

Volumn 5, Issue 6, 1996, Pages 476-482

  Apter, D ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Breast cancer risk; Female puberty; Hormonal events; Menarche

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN;

ADOLESCENT; ADULT; BLOOD LEVEL; BREAST CANCER; CANCER RISK; CONFERENCE PAPER; FEMALE; HUMAN; MENARCHE; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; CHILD; DIET; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PREGNANCY; PUBERTY; RISK FACTORS; TIME FACTORS;

EID: 0030471167     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Apter D (1980). Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol 12: 107-20.
2. Apter D, Vihko R (1977). Serum pregnenolone, progesterone, 17-hydroxyprogesterone, testosterone, and 5-dihydrotestosterone during female puberty. J Clin Endocrinol Metab 45: 1039-48.
3. Apter D, Vihko R (1983). Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 57: 82-6.
4. Apter D, Vihko R (1985). Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol 22: 753-60.
5. Apter D, Vihko R (1990). Endocrine determinants of fertility: serum androgen concentrations during follow-up of adolescents into the third decade of life. J Clin Endocrinol Metab 71: 970-74.
6. Apter D, Sipilä I (1993). Development of children and adolescents: physiological, pathophysiological, and therapeutic aspects. Curr Opin Obstet Gynecol 5: 764-73.
7. Apter D, Bolton NJ, Hammond GL, Vihko R (1984). Serum sex hormone-binding globulin during puberty in girls and in different types of adolescent menstrual cycles. Acta Endocrinol 107: 413-19.
8. Apter D, Räisänen I, Ylöstalo P, Vihko R (1987). Follicular growth in relation to serum hormonal patterns in adolescent compared to adult menstrual cycles. Fertil Steril 47: 82-8.
9. Apter D, Reinila M, Vihko R (1989). Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 44: 783-7.
10. Apter D, Bützow TL, Laughlin GA, Yen SSC (1993). GnRH pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab 76: 940-9.
11. Cacciatore B, Apter D, Alfthan H, Stenman U-H (1991). Ultrasonic characteristics of the uterus and ovaries in relation to pubertal development and serum LH, FSH and estradiol concentrations. Adolesc Pediatr Gynecol 4: 15-20.
12. Colditz GA, Frazier AL (1995). Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4: 567-71.
13. Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347: 1713-27.
14. Damon A, Bajema CJ (1974). Age at menarche: accuracy of recall after thirty-nine years. Hum Biol 46: 381-4.
15. Damon A, Damon ST, Reed RB, Valadian I (1969). Age at menarche of mothers and daughters, with a note on accuracy of recall. Hum Biol 41: 161-75.
16. De Waard F (1991). Endocrine aspects of cancer: an epidemiological approach. J Steroid Biochem Mol Biol 40: 15-19.
17. Döring GK (1969). The incidence of anovular cycles in women. J Reprod Fert 6 (Suppl): 77-81.
18. Friedenreich CM, Rohan TE (1995). Physical activity and risk of breast cancer. Eur J Cancer Prev 4: 145-51.
19. Frisch RE, Wyshak G, Albright NL et al (1985). Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br J Cancer 52: 885-91.
20. Henderson BE, Bernstein L (1991). The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 18 (Suppl 1): S11-S17.
21. Jonnavithula S, Warren MP, Fox RP, Lazaro MI (1993). Bone density is compromised in amenorrheic women despite return of menses: a 2-year study. Obstet Gynecol 81: 669-74.
22. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler Jr GB (1994). Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94: 2475-80.
23. Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe VC (1995). The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80: 898-904.
24. Korenman SG (1980). Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1: 700-1.
25. Loucks AB, Heath EM (1994). Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women. J Clin Endocrinol Metab 78: 910-15.
26. Loucks AB, Vaitukaitis J, Cameron JL et al (1992). The reproductive system and exercise in women. Med Sci Sports Exerc 24: S288-S293.
27. MacMahon B, Trichopoulos D, Brown J et al (1982). Age at menarche, probability of ovulation and breast cancer risk. Int J Cancer 29: 13-16.
28. Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA (1983). Incidence of ovulation in the years after the menarche. J Endocrinol 97: 213-19.
29. Pike MC, Henderson BE, Casagrande JT (1981). The epidemiology of breast cancer as it relates to menarche, pregnancy and menopause. In Hormones and Breast Cancer (Banbury Report No 8) (eds Pike MC, Siiter PK, Welsh C); Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 3-13.
30. Pukkala E, Poskiparta M, Apter D, Vihko V (1993). Life-long physical activity and cancer risk among Finnish female teachers. Eur J Cancer Prev 2: 369-76.
31. Ramos RH, Warren MP (1995). The interrelationships of body fat, exercise, and hormonal status and their impact on reproduction and bone health. Semin Perinatol 19: 163-70.
32. Rogol A (1992). Growth and growth hormone secretion at puberty: the role of gonadal steroid hormones. Acta Paediatr Scand 383 (Suppl): 15-20.
33. Sherman BM, Korenman SG (1974). Inadequate corpus luteum funcion: a pathophysiological interpretation of human breast cancer epidemiology. Cancer 33: 1306-11.
34. Siegel-Witchel S (1995). CNS lesions, neurological disorders, and puberty in man. In The Neurobiology of Puberty (eds Plant TM, Lee PA); Journal of Endocrinology Ltd, Bristol, pp. 229-39.
35. Tokunaga M, Norman JE, Asano M et al (1979). Malignant breast tumors among atomic bomb survivors. Hiroshima and Nagasaki, 1950-74. J Natl Cancer Inst 62: 1347-56.
36. Vihko RK, Apter DL (1986). The epidemiology and endocrinology of the menarche in relation to breast cancer. Cancer Surv 5: 561-71.